{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:49:07Z","timestamp":1792176547056,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Alberta Professorship of Neonatal Resuscitation"},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Stroke Foundation Alberta"},{"DOI":"10.13039\/100010322","name":"Stollery Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["DA029076-01A1"],"award-info":[{"award-number":["DA029076-01A1"]}]},{"name":"National Institute of Health","award":["HD070795-01A1"],"award-info":[{"award-number":["HD070795-01A1"]}]},{"name":"National Institute of Health","award":["U2COD023375-02"],"award-info":[{"award-number":["U2COD023375-02"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","sfnmjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.siny.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T01:09:18Z","timestamp":1549328958000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)"],"prefix":"10.1016","volume":"24","author":[{"given":"A.K.","family":"Mangat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Schm\u00f6lzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.K.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.siny.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"The committee on drugs; the committee on fetus and newborn; American Academy of Pediatrics. Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib2","unstructured":"Neonatal opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm503630.htm."},{"issue":"12","key":"10.1016\/j.siny.2019.01.009_bib3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib4","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib5","series-title":"Basics and therapeutic aspects of perinatal pharmacology","article-title":"A\u00a0scoring system for evaluation and treatment of neonatal abstinence syndrome: a new clinical and research tool","author":"Finnegan","year":"1975"},{"key":"10.1016\/j.siny.2019.01.009_bib6","first-page":"CD002059","article-title":"Opiate treatment for opiate withdrawal in newborn infants","volume":"10","author":"Osborn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.siny.2019.01.009_bib7","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Committee on drugs; committee on fetus and newborn; American Academy of Pediatrics. Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/YCO.0000000000000334","article-title":"Neonatal abstinence syndrome: where are we, and where do we go from here?","volume":"30","author":"Brandt","year":"2017","journal-title":"Curr Opin Psychiatr"},{"issue":"13","key":"10.1016\/j.siny.2019.01.009_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.siny.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","article-title":"The impact of intra-uterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioural studies in children at risk for developmental disorders","volume":"140\u201341","author":"Ornoy","year":"2003","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.siny.2019.01.009_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","article-title":"Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5\u20136 in non-addicted infants","volume":"105","author":"Zimmerman-Baer","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib12","first-page":"376","article-title":"Current status of the management of neonatal abstinence syndrome: results of a national survey","volume":"60","author":"Mehta","year":"2012","journal-title":"J\u00a0Invest Med"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/hpeds.2012-0079","article-title":"Neonatal abstinence syndrome management from prenatal counselling to postdischarge follow-up care: results of a national survey","volume":"3","author":"Mehta","year":"2013","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.siny.2019.01.009_bib14","first-page":"1","article-title":"Nonpharmacological management of neonatal abstinence syndrome: a review of the literature","volume":"8","author":"Ryan","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1542\/peds.2006-2083","article-title":"Swaddling: a systematic review","volume":"120","author":"van Sleuwen","year":"2007","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.siny.2019.01.009_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.jp.7200260","article-title":"Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome","volume":"19","author":"Maichuk","year":"1999","journal-title":"J\u00a0Perinatol"},{"issue":"2","key":"10.1016\/j.siny.2019.01.009_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archpedi.1988.02150020088036","article-title":"Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care","volume":"142","author":"Oro","year":"1988","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005721-199905000-00007","article-title":"Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants","volume":"24","author":"D'Apolito","year":"1999","journal-title":"MCN Am J Matern\/Child Nurs"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","author":"American Academy of Pediatrics","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib20","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk","volume":"129","author":"American Academy of Pediatrics","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib21","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1016\/j.toxlet.2009.06.394","article-title":"Monitoring methadone milk concentrations of metha- done-maintained women in postpartum period for breastfeeding safety","volume":"189","author":"Nikolaou","year":"2009","journal-title":"Toxicol Lett"},{"issue":"6","key":"10.1016\/j.siny.2019.01.009_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/bfm.2010.0060","article-title":"Estimated infant exposure to enantiomer-specific methadone levels in breastmilk","volume":"6","author":"Bogen","year":"2011","journal-title":"Breastfeed Med"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","article-title":"Methadone maintenance and breastfeeding in the neonatal period","volume":"121","author":"Jansson","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.siny.2019.01.009_bib24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/ANC.0b013e318225a30c","article-title":"The impact of infant feeding method on neonatal abstin- ence scores of methadone-exposed infants","volume":"11","author":"McQueen","year":"2011","journal-title":"Adv Neonatal Care"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/jp.2010.66","article-title":"Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syn- drome","volume":"31","author":"Isemann","year":"2011","journal-title":"J\u00a0Perinatol"},{"issue":"11","key":"10.1016\/j.siny.2019.01.009_bib27","first-page":"1060","article-title":"Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants","volume":"102","author":"Welle-Strand","year":"2013","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/bfm.2009.0079","article-title":"Breastfeeding rates among mothers of infants with neonatal abstinence syndrome","volume":"5","author":"Wachman","year":"2010","journal-title":"Breastfeed Med"},{"issue":"2","key":"10.1016\/j.siny.2019.01.009_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1542\/hpeds.2016-0147","article-title":"Impact of parental presence at infants' bedside on neonatal abstinence syndrome","volume":"7","author":"Howard","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"10","key":"10.1016\/j.siny.2019.01.009_bib30","first-page":"1722","article-title":"Rooming-in compared with standard care for newborns of moth- ers using methadone or heroin","volume":"53","author":"Abrahams","year":"2007","journal-title":"Can Fam Physician"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1701-2163(16)35245-8","article-title":"A\u00a0rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn","volume":"34","author":"Hodgson","year":"2012","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib32","doi-asserted-by":"crossref","first-page":"70.e1","DOI":"10.1016\/j.ajog.2008.08.041","article-title":"High-dose metha- done in pregnant women and its effect on duration of neonatal abstinence syndrome","volume":"200","author":"Lim","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1542\/peds.2015-0676","article-title":"Laser acupuncture for neonatal abstinence syndrome: a randomized controlled trial","volume":"136","author":"Raith","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3835","article-title":"Improving care for neonatal abstinence syndrome","volume":"137","author":"Patrick","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib35","article-title":"Neonatal abstinence syndrome: assessment and pharmacotherapy","volume":"vol. 2","author":"Finnegan","year":"1990"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5863\/1551-6776-19.3.147","article-title":"Neonatal abstinence syndrome: essentials for the practitioner","volume":"19","author":"Siu","year":"2014","journal-title":"J\u00a0Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.siny.2019.01.009_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by mu-opioid receptor agonists","volume":"147","author":"Saidak","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.siny.2019.01.009_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)01307-3","article-title":"NMDA receptors as targets for drug action in neuropathic pain","volume":"429","author":"Parsons","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.siny.2019.01.009_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.siny.2019.01.009_bib40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome","volume":"167","author":"Hall","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.siny.2019.01.009_bib41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jcph.696","article-title":"Mechanistic population pharmacokinetics of morphine in neonates with abstinence syndrome after oral administration of diluted tincture of opium","volume":"56","author":"Liu","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.siny.2019.01.009_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1610","article-title":"Population pharmacokinetic model of buprenorphine in pediatric patients with neonatal abstinence syndrome","volume":"35","author":"Ng","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.siny.2019.01.009_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/psp4.12112","article-title":"A\u00a0population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy","volume":"5","author":"Moore","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1542\/peds.2008-0571","article-title":"Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial","volume":"122","author":"Kraft","year":"2008","journal-title":"Pediatric"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"issue":"24","key":"10.1016\/j.siny.2019.01.009_bib46","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","article-title":"Buprenorphine for the treatment of the neonatal abstinence syndrome","volume":"376","author":"Kraft","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2019.01.009_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpeds.2015.11.039","article-title":"A\u00a0cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome","volume":"170","author":"Hall","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0037-1608634","article-title":"Wexelbl att SL: comparison of neonatal abstinence syndrome treatment with sublingual buprenorphine versus conventional opioids","volume":"35","author":"Hall","year":"2018","journal-title":"Am J Perinatal"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.930","article-title":"Buprenorphine in the neonatal abstinence syndrome","volume":"103","author":"Kraft","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5863\/1551-6776-16.4.281","article-title":"Formulation of buprenorphine for sublingual use in neonates","volume":"16","author":"Anagnostis","year":"2011","journal-title":"J\u00a0Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.siny.2019.01.009_bib51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJMc1709121","article-title":"Buprenorphine for the neonatal abstinence syndrome","volume":"377","author":"Kraft","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2019.01.009_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.73.3.405","article-title":"Ethanol in liquid preparations intended for children","volume":"73","author":"Committee on Drugs","year":"1984","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.reprotox.2018.04.006","article-title":"Expression of kappa opioid receptors in developing rat brain - implications for perinatal buprenorphine exposure","volume":"78","author":"Tan","year":"2018","journal-title":"Reprod Toxicol"},{"issue":"1","key":"10.1016\/j.siny.2019.01.009_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.toxlet.2013.12.001","article-title":"Prenatal buprenorphine exposure decreases neurogenesis in rats","volume":"225","author":"Wu","year":"2014","journal-title":"Toxicol Lett"},{"issue":"9","key":"10.1016\/j.siny.2019.01.009_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20675","article-title":"Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain","volume":"56","author":"Sanchez","year":"2008","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1440-1754.2001.00657.x","article-title":"Coordinated outpatient care of the narcotic-dependent infant","volume":"37","author":"Oei","year":"2001","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"7","key":"10.1016\/j.siny.2019.01.009_bib57","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1523\/JNEUROSCI.10-07-02308.1990","article-title":"Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates","volume":"10","author":"Rasmussen","year":"1990","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.siny.2019.01.009_bib59","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jp.2013.95","article-title":"Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial","volume":"33","author":"Surran","year":"2013","journal-title":"J\u00a0Perinatol"},{"issue":"2","key":"10.1016\/j.siny.2019.01.009_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2014-2377","article-title":"Morphine versus clonidine for neonatal abstinence syndrome","volume":"135","author":"Bada","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.01.009_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12887-015-0377-9","article-title":"Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial","volume":"15","author":"Nayeri","year":"2015","journal-title":"BMC Pediatr"},{"issue":"10","key":"10.1016\/j.siny.2019.01.009_bib62","first-page":"CD002053","article-title":"Sedatives for opiate withdrawal in newborn infants","author":"Osborn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0037-1608634","article-title":"Wexelbl att SL: comparison of neonatal abstinence syndrome treatment with sublingual buprenorphine versus conventional opioids","volume":"35","author":"Hall","year":"2018","journal-title":"Am J Perinatal"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mpd.2002.123099","article-title":"Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants","volume":"140","author":"Coyle","year":"2002","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.siny.2019.01.009_bib65","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.111.188862","article-title":"Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats","volume":"340","author":"Forcelli","year":"2012","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.siny.2019.01.009_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1463423618000270","article-title":"Outpatient pharmacologic weaning for neonatal abstinence syndrome: a systematic review","volume":"9","author":"Murphy-Oikonen","year":"2018","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.siny.2019.01.009_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2018.03.048","article-title":"Outpatient pharmacotherapy for neonatal abstinence syndrome","author":"Maalouf","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2019.01.009_bib68","article-title":"Retrospective study found that outpatient care for infants exposed to drugs during pregnancy was sustainable and safe","author":"Rasul","year":"2018","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.siny.2019.01.009_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial","volume":"35","author":"Brown","year":"2015","journal-title":"J\u00a0Perinatol"},{"issue":"5","key":"10.1016\/j.siny.2019.01.009_bib70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.adnc.2005.06.003","article-title":"A\u00a0retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations","volume":"5","author":"Lainwala","year":"2005","journal-title":"Adv Neonatal Care"},{"key":"10.1016\/j.siny.2019.01.009_bib71","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.2146\/sp150025","article-title":"Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome","volume":"72","author":"Young","year":"2015","journal-title":"Am J Health Syst Pharm"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19300186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19300186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T07:32:53Z","timestamp":1662881573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X19300186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1744165X19300186"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2019.01.009","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}